Skip to main content

Research Repository

Advanced Search

Monocyte eukaryotic initiation factor 2 (EIF2) signalling differentiates 17-hydroxy-docosahexaenoic acid levels and pain

Gowler, Peter R.W.; Arendt-Tranholm, Asta; Turnbull, James; Jha, Rakesh R.; Onion, David; Kelly, Tony; Kouraki, Afroditi; Millns, Paul; Gohir, Sameer; Franks, Susan; Barrett, David A.; Valdes, Ana M.; Chapman, Victoria

Monocyte eukaryotic initiation factor 2 (EIF2) signalling differentiates 17-hydroxy-docosahexaenoic acid levels and pain Thumbnail


Authors

Peter R.W. Gowler

Asta Arendt-Tranholm

Rakesh R. Jha

Dr DAVID ONION david.onion@nottingham.ac.uk
ADVANCED TECHNICAL SPECIALIST (FLOW CYTOMETRY)

Paul Millns

Sameer Gohir

Susan Franks

David A. Barrett



Abstract

Our goal was to probe the potential transcriptomic basis for the relationship between plasma levels of the specialized pro-resolving precursor, 17-hydroxy-docosahexaenoic acid (17-HDHA) and chronic pain. Participants with osteoarthritis (average age of 62.3, 60% were female, n = 30) were stratified by levels of 17-HDHA and self-reported pain scores. RNAs from CD14++/CD16-/CD66b-/HLA-DR+ (classical) monocytes were sequenced and differentially expressed mRNAs were identified with DESeq2. QIAGEN ingenuity pathway analysis identified the top ranked canonical biological pathway to be eukaryotic initiation factor 2 (EIF2) signaling (lower activation level in the low 17-HDHA-high pain group compared to the high 17-HDHA-low pain group (Z score −3)), followed by EIF4 and P70S6K signaling pathways and mTOR signaling. Our approach provides insight into the biological pathways contributing to the association between 17-HDHA and chronic osteoarthritis (OA) pain, identifying EIF2 signaling, with known roles in osteoclast differentiation, OA pathology, and pain, as a potential downstream target.

Citation

Gowler, P. R., Arendt-Tranholm, A., Turnbull, J., Jha, R. R., Onion, D., Kelly, T., Kouraki, A., Millns, P., Gohir, S., Franks, S., Barrett, D. A., Valdes, A. M., & Chapman, V. (2025). Monocyte eukaryotic initiation factor 2 (EIF2) signalling differentiates 17-hydroxy-docosahexaenoic acid levels and pain. iScience, 28(2), Article 111862. https://doi.org/10.1016/j.isci.2025.111862

Journal Article Type Article
Acceptance Date Jan 17, 2025
Online Publication Date Jan 21, 2025
Publication Date 2025-01
Deposit Date Mar 6, 2025
Publicly Available Date Mar 7, 2025
Journal iScience
Electronic ISSN 2589-0042
Publisher Cell Press
Peer Reviewed Peer Reviewed
Volume 28
Issue 2
Article Number 111862
DOI https://doi.org/10.1016/j.isci.2025.111862
Public URL https://nottingham-repository.worktribe.com/output/44538594
Publisher URL https://www.sciencedirect.com/science/article/pii/S2589004225001221